Search research articles
Contact Us
Filters
Showing results (591-600 of 750) with videos related to
Page
of 75
Sort By:
PLOS Global Public Health
|
April 20, 2026
Epidemiological patterns of motorcycle-related injuries in Cameroon: A comparative analysis of motorcycle users and pedestrians
Elvis A Tanue, Odette D Kibu, Betrand A Tambe, et al.
Scientific Reports
|
December 18, 2023
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension
Navneet Singh, Carsten Eickhoff, Augusto Garcia-Agundez, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2018
Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2
Nagarajan Muthukaman, Sanjay Deshmukh, Macchindra Tambe, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 5, 2017
Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1
Nagarajan Muthukaman, Macchindra Tambe, Sanjay Deshmukh, et al.
Oral Oncology
|
April 3, 2022
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation
Vijay Patil, Vanita Noronha, Amit Joshi, et al.
European Journal of Medicinal Chemistry
|
June 12, 2024
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Lancet (London, England)
|
August 9, 2025
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial
Prasad S Kulkarni, Anirudha Vyankatesh Potey, Dhananjay Kapse, et al.
Health Promotion International
|
April 1, 2024
Digital tools for youth health promotion: principles, policies and practices in sub-Saharan Africa
Agata Ferretti, Kwame K Adjei, Joseph Ali, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 11, 2017
Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis
Mahesh Thakkar, Debnath Bhuniya, Rahul Kaduskar, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 27, 2023
Gamma secretase activating protein promotes end-organ dysfunction after bacterial pneumonia
Meredith S Gwin, Mikhail F Alexeyev, Aron M Geurts, et al.
Page
of 75
Search research articles
Search
Showing results (591-600 of 750) with videos related to
Sort By:
Page
of 75
PLOS Global Public Health
|
April 20, 2026
Epidemiological patterns of motorcycle-related injuries in Cameroon: A comparative analysis of motorcycle users and pedestrians
Elvis A Tanue, Odette D Kibu, Betrand A Tambe, et al.
Scientific Reports
|
December 18, 2023
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension
Navneet Singh, Carsten Eickhoff, Augusto Garcia-Agundez, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 10, 2018
Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2
Nagarajan Muthukaman, Sanjay Deshmukh, Macchindra Tambe, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 5, 2017
Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1
Nagarajan Muthukaman, Macchindra Tambe, Sanjay Deshmukh, et al.
Oral Oncology
|
April 3, 2022
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation
Vijay Patil, Vanita Noronha, Amit Joshi, et al.
European Journal of Medicinal Chemistry
|
June 12, 2024
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, et al.
Lancet (London, England)
|
August 9, 2025
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial
Prasad S Kulkarni, Anirudha Vyankatesh Potey, Dhananjay Kapse, et al.
Health Promotion International
|
April 1, 2024
Digital tools for youth health promotion: principles, policies and practices in sub-Saharan Africa
Agata Ferretti, Kwame K Adjei, Joseph Ali, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 11, 2017
Discovery and evaluation of 1H-pyrrolo[2,3-b]pyridine based selective and reversible small molecule BTK inhibitors for the treatment of rheumatoid arthritis
Mahesh Thakkar, Debnath Bhuniya, Rahul Kaduskar, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 27, 2023
Gamma secretase activating protein promotes end-organ dysfunction after bacterial pneumonia
Meredith S Gwin, Mikhail F Alexeyev, Aron M Geurts, et al.
Page
of 75